Research Center Profile:
Hattiesburg Clinic Neurological Research Center
The Neurological Research Center (NRC) is a service of Hattiesburg Clinic. Our goal is to partner with both academia and industry to provide the residents of South Mississippi with access to leading-edge clinical trials.
The NRC has conducted phase II, III, and IV clinical trials with focus on neurological disease. The NRC is able to utilize a Central Institutional Review Board. The Center's special interests include Alzheimer disease, Parkinson's disease, epilepsy, stroke, migraine, as well as other disorders that affect the nervous system. The center has been involved in clinical research since 2005.
NRC physicians provide evaluation and treatment in both the inpatient and outpatient setting. The center has On-site laboratory (certified by the State Board) -20 C freezer, dry ice, centrifuge; On-site full service pharmacy; On-site imaging department with 1.5 Tesla Magnetic Resonance Imaging and 3 Tesla Magnetic Resonance Imaging, PET Imaging, 64 slice CT scanner, Densitometry, Nuclear Medicine, and Ultrasound; Neurodiagnostics including Electroencephalography (EEG), 24-hour EEG/Video Monitoring, Electromyography (EMG) and nerve conduction, Electronystagmography (ENG), and Tilt table; Neuropsychological testing and dedicated, secure research space.
Located within Hattiesburg Clinic, a physician-owned group practice with more than 200 physicians, NRC is staffed by board certified Neurologists who oversee all aspects of clinical trials. Support Personnel include a study coordinator and clinical study manager who provide services necessary for the efficient achievement of research objectives.
We are located across the street from Forrest General Hospital, a 512 bed, level II regional trauma center.
Ronald L. Schwartz, MD
Director and Principle Investigator
Dr. Schwartz graduated from Columbia College, in New York City with a Bachelor of Arts degree in English. He attended medical school at Albany Medical College, in Albany, New York. He completed his Neurology residency at Albert Einstein College of Medicine in Bronx, New York where he also served as chief resident in Neurology. Dr. Schwartz completed a fellowship in Behavioral Neurology at the University of Florida, in Gainesville. Dr. Schwartz has been actively involved in clinical research, including pharmaceutical trials, since 1996.
Sub-Investigators: Jose P. Fernandez, Jr., M.D., Wendell R. Helveston, M.D., C. Scott Lynn, M.D., Joshua A. Maksi, M.D., Gabriella Szatmary, MD
Neuropsychology: Andrew L. Dickson, Ph.D., Jeffrey Schneider, Ph.D.
Jennifer Aultman, LPN, CRC
Clinical Research Coordinator
8 years experience coordinating studies
Patients will be chosen from our clinic database, advertisements, referrals, etc.
The NRC is able to utilize a Central Institutional Review Board.
Jennifer Aultman
Clinical Research Coordinator
Hattiesburg Clinic Neurological Research Center
415 S 28th Ave
Hattiesburg, MS 39401
USA
Phone: 601-579-5345
Fax: 601-579-5328
EMail: jennifer.aultman@hattiesburgclinic.com
Web Site: http://www.hattiesburgclinic.com
The following trial(s) are actively recruiting patients:
- A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Trial of Bapineuzumab in Subjects With Mild to Moderate Alzheimer Disease Who Are Apolipoprotein E e4 Carriers
- A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Trial of Bapineuzumab (AAB-001, ELN115727) In Patients With Mild to Moderate Alzheimer's Disease Who Are Apolipoprotein E4 Non- Carriers
- Effect of LY450139 a y-Secretase Inhibitor, on the Progression of Alzheimer's Disease as Compared With Placebo
- Effect of Passive Immunization on the Progression of Alzheimer's Disease: LY2062430 Versus Placebo
If you are interested in contacting this center to discuss placing a clinical
trial there, please complete and send the E-mail form below. A representative from
the research center will then follow up with you.
